Jasper Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell JSPR and other ETFs, options, and stocks.About JSPR
Jasper Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in enabling cures through hematopoietic stem cell therapy. It focuses on the development and commercialization of safer, stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic manipulation of cells is performed outside of the body prior to transplantation.
CEORonald A. Martell
CEORonald A. Martell
Employees64
Employees64
HeadquartersRedwood City, California
HeadquartersRedwood City, California
Founded2018
Founded2018
Employees64
Employees64
JSPR Key Statistics
Market cap50.25M
Market cap50.25M
Price-Earnings ratio-0.64
Price-Earnings ratio-0.64
Dividend yield—
Dividend yield—
Average volume2.40M
Average volume2.40M
High today$3.48
High today$3.48
Low today$3.26
Low today$3.26
Open price$3.40
Open price$3.40
Volume350.33K
Volume350.33K
52 Week high$26.05
52 Week high$26.05
52 Week low$2.27
52 Week low$2.27
Analyst ratings
60%
of 10 ratingsBuy
60%
Hold
40%
Sell
0%
People also own
Based on the portfolios of people who own JSPR. This list is generated using Robinhood data, and it’s not a recommendation.